142 results on '"Panichi, Vincenzo"'
Search Results
2. RAASi Therapy Attenuates the Association between 24-h Urinary Potassium Excretion and Dietary Potassium Intake in CKD Patients
3. Citrate anion improves chronic dialysis efficacy, reduces systemic inflammation and prevents Chemerin-mediated microvascular injury
4. Vitamin D and Calcium Supplementation and Urolithiasis: A Controversial and Multifaceted Relationship
5. Mediterranean Dietary Pattern Adjusted for CKD Patients: The MedRen Diet
6. Kidney Stone Prevention: Is There a Role for Complementary and Alternative Medicine?
7. Diagnosis, Prevalence and Significance of Obesity in a Cohort of CKD Patients
8. Efficacy, Safety and Pharmacoeconomic Analysis of Intravenous Ferric Carboxymaltose in Anemic Hemodialysis Patients Unresponsive to Ferric Gluconate Treatment: A Multicenter Retrospective Study
9. Nutritional Treatment as a Synergic Intervention to Pharmacological Therapy in CKD Patients.
10. Mediterranean Dietary Pattern Adjusted for CKD Patients: The MedRen Diet.
11. High-volume online haemodiafiltration improves erythropoiesis-stimulating agent (ESA) resistance in comparison with low-flux bicarbonate dialysis: results of the REDERT study
12. Endothelial progenitor cell-derived extracellular vesicles protect from complement-mediated mesangial injury in experimental anti-Thy1.1 glomerulonephritis
13. Extracellular Vesicles Derived from Endothelial Progenitor Cells Protect Human Glomerular Endothelial Cells and Podocytes from Complement- and Cytokine-Mediated Injury
14. Ochratoxin A-Induced Renal Cortex Fibrosis and Epithelial-to-Mesenchymal Transition: Molecular Mechanisms of Ochratoxin A-Injury and Potential Effects of Red Wine
15. Soluble CD40 ligand is predictive of combined cardiovascular morbidity and mortality in patients on haemodialysis at a relatively short-term follow-up
16. Reply
17. Anaemia and resistance to erythropoiesis-stimulating agents as prognostic factors in haemodialysis patients: results from the RISCAVID study
18. Reply
19. Smell and Taste in Severe CoViD-19: Self-Reported vs. Testing
20. Impact of calcium, phosphate, PTH abnormalities and management on mortality in hemodialysis: Results from the RISC AVID study
21. Dimethylarginine levels and nutritional status in hemodialysis patients
22. Results from the RISCAVID study: is haemodiafiltration associated with improved survival?
23. Chronic inflammation and mortality in haemodialysis: effect of different renal replacement therapies. Results from the RISCAVID study
24. Agalsidase therapy in patients with Fabry disease on renal replacement therapy: a nationwide study in Italy
25. Effect of simvastatin on plasma asymmetric dimethylarginine concentration in patients with chronic kidney disease
26. Theoretical calculation of optimal depth in the percutaneous native kidney biopsy to drastically reduce bleeding complications and sample inadequacy for histopathological diagnosis
27. The Pisa experience of renal biopsies, 1977-2005
28. Soy protein diet improves endothelial dysfunction in renal transplant patients
29. Effects on inflammatory and nutritional markers of haemodiafiltration with online regeneration of ultrafiltrate (HFR) vs online haemodiafiltration: a cross-over randomized multicentre trial
30. In vivo and in vitro effects of simvastatin on inflammatory markers in pre-dialysis patients
31. Challenges in acute and chronic renal failure: MO13 EFFECTS ON INFLAMMATORY AND NUTRITIONAL MARKERS OF HEMODIAFILTRATION WITH ONLINE REGENERATION OF ULTRAFILTRATE (HFR) VERSUS ON-LINE HEMODIAFILTRATION: A CROSS-OVER RANDOMIZED MULTICENTER TRIAL
32. Enzyme replacement therapy with agalsidase beta in kidney transplant patients with Fabry disease: A pilot study
33. Interleukin-6 is a stronger predictor of total and cardiovascular mortality than C-reactive protein in haemodialysis patients
34. Correction to: Citrate high volume on-line hemodiafiltration modulates serum Interleukin-6 and Klotho levels: the multicenter randomized controlled study 'Hephaestus'
35. INTERLEUKIN 6 IS A STRONGER PREDICTOR OF TOTAL AND CARDIOVASCULAR MORTALITY THAN C-REACTIVE PROTEIN IN DIALYTIC PATIENTS
36. CERULOPLASMIN AND COPPER LEVELS ARE RELATED TO MORE CLASSICAL INFLAMMATION MARKERS IN CHRONIC DIALYTIC PATIENTS
37. COMPARISON OF THREE AUTOMATED C-REACTIVE PROTEIN (CrP) METHODS IN END STAGE RENAL DISEASE (ESRD): CLINICAL AND EPIDEMIOLOGICAL IMPLICATIONS
38. ENZYME REPLACEMENT THERAPY WITH AGALSIDASE β IN FABRYʼS DISEASE PATIENTS WITH KIDNEY TRANSPLANTATION: RESULTS AFTER 1 YEAR OF TREATMENT
39. PODOCYTES AS POTENTIAL TARGET FOR 1,25-DIHIDROXYVITAMIN D3 TREATMENT IN ANTI-THY-1.1 NEPHRITIS
40. EFFECT OF “PHYSIOLOGICAL” CONCENTRATION OF SOME NATURAL ANTIOXIDANT PHENOLS ON NITRIC OXIDE RELEASE FROM ENDOTHELIAL CELLS IN VITRO
41. ROLE OF BLOOD PRESSURE ON CHRONIC INFLAMMATION AND ENDOTHELIAL FUNCTION IN UNTREATED ESSENTIAL HYPERTENSIVE PATIENTS
42. Inflammation, CRP, calcium overload and a high calcium–phosphate product: a ‘liaison dangereuse’
43. Effects of 1,25(OH)2D3 in experimental mesangial proliferative nephritis in rats
44. FO048REMOVAL OF LARGE-MIDDLE MOLECULES, INHIBITION OF NEUTROPHIL ACTIVATION AND MODULATION OF INFLAMMATION-RELATED ENDOTHELIAL DYSFUNCTION DURING EXPANDED HEMODIALYSIS (HDx)
45. Calcitriol modulates in vivo and in vitro cytokine production: A role for intracellular calcium
46. The link of biocompatibility to cytokine production
47. FP069ROLE OF SOLUBLE FORM AND EXTRACELLULAR VESICLE (EV)-CARRIED CD40LIGAND (CD40L) AS BIOMARKER OF DISEASE ACTIVITY AND AS MEDIATOR OF MICROVASCULAR ENDOTHELIAL INJURY IN CRITICALLY ILL PATIENTS WITH ACUTE KIDNEY INJURY (AKI) AND IN END STAGE RENAL DISEASE (ESRD) PATIENTS
48. FP690SAFETY OF CHEMOTHERAPY FOR ADVANCED NON-SMALL-CELL LUNG CANCER IN CHRONIC HEMODIALYTIC PATIENTS
49. SP580THE ARTERIOVENOUS GRAFT BETWEEN THE BRACHIAL ARTERY AND VENA COMITANS: A RELIABLE VASCULAR ACCESS IN PATIENTS WITH INADEQUATE SUPERFICIAL VEINS
50. Efficacy of a remote web-based lung ultrasound training for nephrologists and cardiologists: a LUST trial sub-project
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.